SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
Craig the beer-ambassador elephant dies aged 54 - 2The most effective method to Pick the Right Material Organization: Your Definitive Aide
- 3King Charles shares cancer treatment update, says it's a 'personal blessing'
- 4This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- 5Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- Addiction-stricken community struggles to keep a syringe program going after Trump's order
- Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- Kate Hudson, 46, says she doesn't need long workouts to feel good
- The most effective method to Stay away from Normal Traps While Recruiting a Material Organization
- National health ranking puts Georgia near bottom of list. Here's why
- Surveys of Music Collections by Film Stars
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- Instructions to Decide the Best SUV Size for Seniors
- NASA's Voyager 1 set to achieve historic distance from Earth
